Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Isofol Medical AB (ISOFOL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014069
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company developing folate-based therapies for the treatment of cancer patients. The company’s clinical lead candidate Modufolin, a metabolite is under clinical phase I/II development being evaluated for the treatment of colorectal cancer and osteosarcoma. Isofol’s product helps in improving efficacy and reducing side effects of antimetabolites in cancer treatments. Isofol’s focuses to improve the outlook of cancer patients undergoing chemotherapy treatments It also offers research and development services. The company works in collaboration with Merck & Cie , Recipharm AB. Isofol is headquartered in Gothenburg, Sweden.

Isofol Medical AB (ISOFOL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Isofol Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Isofol Medical AB, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Isofol Medical Raises USD1.2 Million in Venture Financing 10
Licensing Agreements 11
Isofol Medical Enters Into Licensing Agreement With Merck For Modufolin 11
Equity Offering 12
Isofol Medical Raises USD48.6 Million in IPO 12
Isofol Medical Raises USD4.7 Million in Public Offering of Shares 13
Isofol Medical AB – Key Competitors 14
Isofol Medical AB – Key Employees 15
Isofol Medical AB – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Isofol Medical AB, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Isofol Medical AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Isofol Medical AB, Deals By Therapy Area, 2011 to YTD 2017 8
Isofol Medical AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Isofol Medical Raises USD1.2 Million in Venture Financing 10
Isofol Medical Enters Into Licensing Agreement With Merck For Modufolin 11
Isofol Medical Raises USD48.6 Million in IPO 12
Isofol Medical Raises USD4.7 Million in Public Offering of Shares 13
Isofol Medical AB, Key Competitors 14
Isofol Medical AB, Key Employees 15

★海外企業調査レポート[Isofol Medical AB (ISOFOL)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BBMG Corporation:企業の戦略・SWOT・財務情報
    BBMG Corporation - Strategy, SWOT and Corporate Finance Report Summary BBMG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Britannia Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • African Development Bank Group:企業の戦略的SWOT分析
    African Development Bank Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Policolor SA:企業の戦略的SWOT分析
    Policolor SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Stellar Resources Ltd
    Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Tivoli A/S:企業の戦略・SWOT・財務分析
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Enzo Clinical Labs Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc, is a medical laboratory that provides testing services. The company develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets, among others. It provides …
  • AnaBios Corp-製薬・医療分野:企業M&A・提携分析
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization which carries out drug efficacy studies on human samples. Its products portfolio includes human dorsal root ganglia (hDRG) neuron cultures, human heart tissue samples,human cardiac mesenchymal stem cells, human bra …
  • Owensboro Municipal Utilities:企業の戦略的SWOT分析
    Owensboro Municipal Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Century Plyboards (India) Ltd:企業の戦略・SWOT・財務情報
    Century Plyboards (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Century Plyboards (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Republic Services Inc (RSG):企業の財務・戦略的SWOT分析
    Republic Services Inc (RSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • German Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Ajinomoto Co Inc (2802):製薬・医療:M&Aディール及び事業提携情報
    Summary Ajinomoto Co Inc (Ajinomoto) is a food products company that focuses on foods, bioscience fine chemicals and pharmaceuticals and health. It carries out research and development and production of seasonings, and provides Knorr cup soup products, processed foods, edible oils, sweeteners, bever …
  • ASGN Inc (ASGN):企業の財務・戦略的SWOT分析
    Summary ASGN Inc (ASGN), formerly known as On Assignment Inc, provides professionals for technology, life sciences, and creative sectors. It offers qualified professionals and human capital services. The company’s cybercoders recruits professionals for engineering, technology, sales, executive, fina …
  • Mahindra & Mahindra Limited:戦略・SWOT・企業財務分析
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Panacea Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Panacea Pharmaceuticals Inc (Panacea) is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutic and diagnostic products for the treatment of cancer and central nervous system diseases. The company’s pipeline products include PAN-301-1, a human aspa …
  • Camlin Fine Sciences Limited:戦略・SWOT・企業財務分析
    Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report Summary Camlin Fine Sciences Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • De La Rue Plc:企業の戦略・SWOT・財務分析
    De La Rue Plc - Strategy, SWOT and Corporate Finance Report Summary De La Rue Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Jungheinrich AG:企業の戦略・SWOT・財務情報
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆